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Abstract
Background: Mobile phone-based psychological interventions enable real time self-monitoring and self-management,
and large-scale dissemination. However, few studies have focussed on mild-to-moderate symptoms where public
health need is greatest, and none have targeted work and social functioning. This study reports outcomes of a
CONSORT-compliant randomised controlled trial (RCT) to evaluate the efficacy of myCompass, a self-guided
psychological treatment delivered via mobile phone and computer, designed to reduce mild-to-moderate depression,
anxiety and stress, and improve work and social functioning.
Method: Community-based volunteers with mild-to-moderate depression, anxiety and/or stress (N = 720) were
randomly assigned to the myCompass program, an attention control intervention, or to a waitlist condition for
seven weeks. The interventions were fully automated, without any human input or guidance. Participants’ symptoms
and functioning were assessed at baseline, post-intervention and 3-month follow-up, using the Depression, Anxiety
and Stress Scale and the Work and Social Adjustment Scale.
Results: Retention rates at post-intervention and follow-up for the study sample were 72.1% (n = 449) and 48.6%
(n = 350) respectively. The myCompass group showed significantly greater improvement in symptoms of depression,
anxiety and stress and in work and social functioning relative to both control conditions at the end of the 7-week
intervention phase (between-group effect sizes ranged from d = .22 to d = .55 based on the observed means).
Symptom scores remained at near normal levels at 3-month follow-up. Participants in the attention control condition
showed gradual symptom improvement during the post-intervention phase and their scores did not differ from the
myCompass group at 3-month follow-up.
Conclusions: The myCompass program is an effective public health program, facilitating rapid improvements in
symptoms and in work and social functioning for individuals with mild-to-moderate mental health problems.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN 12610000625077
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Background
Anxiety and depressive disorders are common mental
health conditions with global lifetime prevalence rates of
28.8% and 16.6% respectively [1]. Both are associated
with substantial impairment [2,3]. Public health interven-
tions are needed for individuals with mild-to-moderate
symptoms to reduce the risk of work and social disability,
loss of quality of life, symptom exacerbation and co-existing
health complications, as well as to mitigate economic conse-
quences including increased health costs and reduced work
productivity [4,5]. Decrements in work productivity due to
depression alone costs an estimated US $33 billion annually
in lost revenue and accounts for the largest proportion of
the personal financial burden on sufferers [5]. However, the
majority of people with common mental health conditions
do not access professional help, despite the existence
of effective psychological and pharmacological treat-
ments [6]. Reasons include lack of service availability
(especially in rural and remote areas), problems recog-
nising symptoms, treatment cost, time constraints and
concerns about confidentiality and stigma [7,8].
Web-based psychological interventions can facilitate
access to empirically supported treatments, and are popu-
lar with users [9], cost-effective [10] and clinically effica-
cious, with effect sizes similar to face-to-face therapy [11].
Whereas these interventions have predominantly been
available on desktop computers, mobile phones offer
several further advantages. Practically, their wide-spread
ownership (currently 6 billion subscriptions worldwide
[12]), multiple functionalities including internet linkage,
and the fact that they are generally carried on the person
and turned on, makes mobile phones an ideal platform for
broad dissemination of effective psychotherapies. Clinic-
ally, mobile phones have the capacity to support ecological
momentary assessment and ecological momentary inter-
vention (EMA and EMI); that is, self-monitoring of symp-
toms and behaviours and provision of psychotherapeutic
advice in real-time and in real-world contexts [13].
The number of mobile mental health interventions is
increasing rapidly, although research into their efficacy
is not occurring at the same pace [13]. Predominantly,
extant research has been confined to small, non-controlled,
and non-randomised studies without long-term follow-up
[14], with only a few exceptions [15,16]. Furthermore, none
of the studies has tested the effects of mobile interventions
on work and social functioning, where the personal and
socio-economic burden is great.
We have previously reported data from a proof of con-
cept study suggesting the feasibility of an intervention
that combines web and mobile technologies for improving
psychological well being [14]. The myCompass program
(www.myCompass.org.au) is an automatic, self-guided, pub-
lic health program aimed at facilitating self-management of
common mental health problems. Grounded in cognitive
behavioural therapy (CBT), and incorporating elements of
Problem Solving Therapy, Interpersonal Psychotherapy and
Positive Psychology, the myCompass program combines
round-the-clock availability of psychotherapeutic resources
with EMA (via mobile phone and computer). In the quasi-
experimental study, 49 people with mild-to-moderate men-
tal health symptoms showed significant improvements in
depression, anxiety and stress and overall psychological dis-
tress after using the program for six weeks. Furthermore, a
high level of satisfaction with the myCompass intervention
was reported [14].
The aim of this paper is to report the outcomes of a
CONSORT-compliant randomised controlled trial (RCT)
to evaluate the efficacy of the myCompass program in a
large community sample of people experiencing mild-to-
moderate depression, anxiety and/or stress. We predicted
that symptoms of depression, anxiety and stress would
reduce in participants randomly allocated to receive
myCompass, relative to both attention control (AC)
and waitlist (WL) conditions. We also predicted that
use of myCompass would increase work and social
functioning relative to the AC and WL conditions. To
our knowledge, this is the first trial to examine a fully
automated, self-help, mobile phone and web-based
intervention for common mental health problems and
work and social functioning in a community sample.
Methods
Eligibility criteria
Participants were required to meet the following criteria:
Australian resident aged 18 to 75 years; own an internet-
enabled mobile phone; have access to a desk-top com-
puter with internet capability; have a valid email address;
and report symptoms of mild-to-moderate depression,
anxiety and/or stress, defined as a total score of 27–63
inclusive on the Depression Anxiety and Stress Scales
(DASS; [17]). Consistent with our public health focus on
mild-to-moderate symptoms, people were excluded if they
scored 64 or more on the DASS (severe symptomatology),
answered positively to questions asking about suicidal
thoughts, intent and/or previous suicide attempts, or met
criteria for psychotic symptoms, as measured by the
Psychosis Screening Questionnaire (PSQ; [18]).
Sample & setting
Based on data from our proof of concept study [14], our
targeting of mild-to-moderate symptoms, and the fact
that myCompass is a self-help intervention without ther-
apist support, we estimated a between-group effect size
of d = 0.2. Power calculations established that for 80%
power and an alpha of .05, 400 people per group would
be required to detect a difference if one was present. To
allow for sample attrition, we set a sample size target of
n = 650 per group. Participants were recruited nationally
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and online between October 2011 and March 2012 via
social media (Facebook and Twitter), websites of the
Black Dog Institute (BDI), corporate and government or-
ganisations, advertisements placed on national radio and
in print media, and the BDI volunteer research register.
Due to time and funding restrictions, it was not possible
to extend recruitment activities beyond this period.
Written informed consent was provided by all partici-
pants. The RCT was approved by the Human Research
Ethics Committee at the University of New South Wales,
Sydney, Australia (HREC 100019), and registered as
Australian New Zealand Clinical Trials Registry ACTRN
12610000625077.
Design
A mixed factorial repeated measures design was employed,
with full randomisation to three conditions.
Randomisation
A research assistant not involved in the RCT rando-
mised participants after baseline using computerised
random numbers. Allocation was either to the myCom-
pass, AC or WL condition. Participants received advice
of their group assignment by email.
Interventions
myCompass is a fully-automated, self-help, public health
intervention, that is tailored to the user and has no therapist
input. Real-time self-monitoring of symptoms (e.g., problem
moods, thoughts and behaviours) via mobile phone and/or
computer is a key therapeutic feature. Users can self-
monitor three symptoms of their choice at any one time, se-
lected from a list of 20, or three that are recommended to
them by the program (e.g., confidence, worry, irritability,
motivation, diet, and medication use). Each symptom is
rated on a 10-point scale (e.g., “how confident do you feel
right now”, “how worried do you feel right now”, “how satis-
fied are you that you have taken your prescribed medication
today”). At the time of rating, users also provide contextual
information about where they are, what they are doing and
who they are with, using a series of drop-down menus.
Users can schedule short message service (SMS) or email re-
minders to facilitate self-monitoring (frequency of reminders
determined by the user); receive and print graphical feed-
back about their monitoring, including contextual informa-
tion, on their phone or computer (to monitor change and
assist identification of triggers); and elect to receive helpful
facts, mental health-care tips or motivational statements by
SMS or email.
Evidence-based and interactive psychological modules
that users can complete via the internet on their computers
are another key element of myCompass. The program con-
tains 12 skill-building modules derived from CBT, Inter-
personal Psychotherapy, Problem-solving Therapy and
Positive Psychology that cover topics such as Man-
aging Fear and Anxiety, Tackling Unhelpful Thinking,
Managing Loss and Major Life Change, and Solving
Problems. Each module comprises three 10-minute
sessions and includes activities for users to complete
on the computer. Modules also recommend home
practice tasks for completion between the weekly sessions
to promote skill generalisation. Users can complete the
modules of their choice, or those recommended to them
by the myCompass program.
Tailoring of the myCompass program self-monitoring
and module recommendations occurs via users’ re-
sponses to a profile questionnaire completed at registra-
tion. This questionnaire asks users to rate the extent to
which they experience a range of symptoms of depres-
sion, anxiety, and stress (e.g., worry, irritability, difficul-
ties with motivation and concentration). Targeting the
three highest rated symptoms, in-built algorithms gener-
ate personalised feedback to the user about the self-
monitoring dimensions and psychological modules that
may be of greatest benefit (i.e., each dimension and
module is weighted according to its clinical relevance for
each symptom, and those with the highest weightings
are recommended).
User privacy is managed by a password protected log-
on, and by ensuring that user generated data (i.e., self-
monitoring ratings) are not stored on the users’ phone
but instead transferred via the internet using secure
sockets layer protocols (which encrypt transmitted data
by rendering it unreadable to anyone other than the
intended recipient) and by storing the data in secure
servers. Registering to use myCompass is free and users
are not billed for the SMSs they receive.
Participants randomised to the myCompass interven-
tion were emailed instructions for accessing and logging
onto the program. They were advised that they had full
access to the program for seven weeks, and were en-
couraged to use the program ad libitum during this
time. However, it was recommended that they complete
a minimum of two modules and monitor daily at least
three moods or behaviours during the intervention
phase. Access to the program was withdrawn at the end
of seven weeks.
Attention control participants received a control men-
tal health program matched to the active intervention
on duration and mode of delivery. Each week for seven
weeks, they received a fact sheet containing information
about depression, anxiety or stress sent to their email
address. The information was designed to be read on
computer in approximately 10 minutes, and to be cred-
ible but void of management advice or treatment strat-
egies. They also received on their mobile phones weekly
SMS messages containing brief factual statements about
depression, anxiety and stress. The mobile phone statements
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were also therapeutically inactive, but chosen to ensure that
the control program had face validity. Messages varied in
length from 160 to 275 characters so as to match, as far as
possible, the minimum amount of SMS content that
myCompass participants received each week, namely one
self-monitoring reminder (160 characters) plus an op-
tional motivational statement, mental health care tip or
fact (average length 95 characters).
Waitlist participants did not receive emails or SMSs
during the intervention phase, but received full access to
the myCompass program at the end of the seven weeks.
By including both the AC group and the WL group,
we were able to control for non-specific effects of the
intervention. We were also able to test whether any ef-
fects seen during the intervention phase were replicated
when the WL control group subsequently completed the
myCompass program.
Procedure
Data collection took place between October 2011 and
October 2012. All study consent, screening and ques-
tionnaire data were collected online using online survey
software. Individuals not meeting screening criteria re-
ceived automated feedback explaining the reason/s for
their ineligibility, and referring them to other online re-
sources of the BDI. Individuals with symptoms in the se-
vere range were also advised to seek face-to-face support
from a health professional and were provided the con-
tact details of crisis support services.
Eligible participants completed a baseline question-
naire prior to randomisation, a post-intervention ques-
tionnaire administered at eight weeks, and a follow-up
questionnaire administered 12 weeks later for partici-
pants in the myCompass and AC groups, and 19 weeks
later for the WL group. At each assessment point, par-
ticipants accessed the appropriate study questionnaire
via a link sent to them in an email message.
Primary outcome
The Depression, Anxiety and Stress Scales measure (DASS-
21; [17]) is a widely used self-report measure of depression,
anxiety and stress with high internal consistency, accept-
able test-retest reliability [19], and yields reliable and valid
data when used in an online format [20]. Respondents are
asked to indicate the frequency with which they experi-
enced symptoms of depression, anxiety and stress over the
previous week. Total scores range from 0 to 126 and sub-
scale scores range from 0 to 42, with higher scores indicat-
ing greater symptom severity.
Secondary outcomes
The Work and Social Adjustment Scale (WSAS; [21]) as-
sesses the degree to which mental health problems inter-
fere with day-to-day functioning in five domains: work,
social leisure activities, private leisure activities, home-
management, and personal relationships [21]. The meas-
ure provides an assessment of the experiential impact of
mental health symptoms from the sufferer’s point of
view. Scores range from 0 to 40, with higher scores indi-
cating poorer adjustment. Meyer et al. [22] provide data
supporting the psychometric adequacy of the WSAS
when administered in an online format.
Demographic and clinical information collected within
the baseline questionnaire included age, gender, marital
status, educational level, employment status, frequency
of mobile phone and internet use, frequency of depres-
sive and anxiety episodes, and age of first episode. At
each assessment point, health service utilisation for
mental health reasons (e.g., visits to general practitioner,
mental health professionals and alternative health practi-
tioners) and use of antidepressant and anxiolytic medica-
tion were also assessed. Satisfaction with the program
was measured at post-intervention for participants in
the myCompass and AC groups using a study-specific
measure assessing users’ perceptions of program usabil-
ity, content, flexibility and functionality.
Adherence, defined as the extent to which participants
engaged with the intervention [23], was examined for
the myCompass group with respect to three indices,
namely, frequency of logins, frequency of self-monitoring,
and number of modules attempted.
Statistical analyses
Statistical analyses were completed with SPSS 20.0 soft-
ware. Characteristics of the three groups at baseline were
compared using chi-square tests for categorical variables
and analysis of variance (ANOVA) for continuous vari-
ables. Chi-square and ANOVA were also used to com-
pare baseline characteristics of participants who did
(‘non-dropouts’) and did not (‘dropouts’) return com-
pleted questionnaires at post-intervention and follow-up,
to explore possible biases in attrition.
Effects of the myCompass intervention on study out-
comes were evaluated using intention-to-treat (ITT)
analyses that included data from all participants who
completed the baseline assessment and any follow-up as-
sessment. Strategies for dealing with missing data in lon-
gitudinal studies vary, so we adopted two recommended
techniques for analysing incomplete datasets, namely,
mixed models repeated measures (MMRM) and multiple
imputation (MI; for a review see [24]). The two analyses
yielded similar outcomes and, as MMRM is the dominant
strategy adopted in studies of web-based interventions,
the findings derived from MMRM are presented here.
In MMRM, no participant is removed from the analysis
because all available data is used to obtain parameter esti-
mates. In the present study, restricted maximum likelihood
(REML) was used to estimate model parameters and error
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degrees of freedom were calculated using Satterthwaite’s
approximation [25]. Analyses assumed a compound sym-
metric structure, in line with Fairclough’s recommendation
that the covariance structure be restricted in situations
where attrition is high [26].
Post-intervention analyses involved a series of 3 groups
(myCompass, AC and WL) by 2 times (pre-intervention,
post-intervention) repeated measures models. Because
WL participants were exposed to the myCompass inter-
vention during the follow-up period, repeated measures
models analysing follow-up data comprised 2 groups
(myCompass and AC) by 3 times (pre, post and follow-
up). For each analysis, scores at baseline on the outcome
variable of interest was entered as a covariate. Significant
group by time interaction effects were examined using
sets of Bonferroni adjusted interaction contrasts to
compare between-group differences in mean change
on the outcome measure from baseline to post-intervention
(i.e., intervention period) and from post-intervention to
follow-up (i.e., follow-up phase), as appropriate. All effects
were tested at the p < 0.05 level, with adjustment according
to the number of contrasts in each set.
Cohen’s d was calculated following the procedure out-
lined in Ruwaard et al. [27] and using both observed and
estimated marginal means. For all outcome measures,
within-and between-group differences were standardised
to Cohen’s d using the pooled standard deviation of the
observed scores obtained at baseline.
Assessed for eligibility (n= 2475)
Excluded (n = 1755)
Not meeting inclusion criteria (n = 1358)
Did not return pre-intervention (T1)
questionnaire (n = 266)
T1 questionnaire incomplete (n = 128)
Withdrawn (n = 3)
Follow-up assessment
(n = 100)
Lost to follow-up (n = 130)
Post-intervention assessment 
(n = 126) 
Lost to follow-up (n = 105)
Allocated to myCompass 
intervention (n = 242) 
Withdrawn (n = 11)
Post-intervention assessment 
(n = 198)
Withdrawn (n = 2)
Lost to follow-up (n = 30)
Allocated to waiting list
(n = 230)
Withdrawn (n = 2)
Follow-up assessment 
Lost to follow-up (n = 145)
Allocation
Follow-up
Randomized (n=720)
Enrollment
Follow-up assessment
(n = 167)
Lost to follow-up (n = 79)
Post-intervention assessment 
(n = 195)
Withdrawn (n = 2)
Lost to follow-up (n = 51)
Allocated to Attention Control 
(n = 248)
Withdrawn (n = 2)
Consented to screening (n= 2955)
EOI received and consent and screening 
information sent (n= 3561)
Excluded – screening questionnaire 
incomplete (n=480)
2nd post-intervention 
assessment  
(n = 103)
(n= 83) 
Figure 1 Participant flow diagram.
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To determine the replicability of treatment effects
resulting from the intervention, primary and secondary
outcome data from WL participants who used the
myCompass program at the end of their waiting period
were examined at post-intervention and follow-up using
paired samples t-tests and Cohen’s d.
Results
Randomisation and study attrition
Details of enrolment into the trial, organised according
to the CONSORT guidelines [28], are shown in Figure 1.
Of the 3561 people who expressed an interest in the
study, 720 were randomised. Among those who returned
completed screening information, reasons for ineligibility
included: symptoms too severe (975, 73.1%); no internet-
enabled mobile phone (167, 12.3%); symptoms in the
normal range (150, 11%); no access to the internet or
mobile phone (49, 3.6%) and not an Australian resident
(17, 0.01%). Fifteen people subsequently withdrew from
the study and, in the absence of consent to use their
data, we excluded them from the analyses.
The recruitment process yielded a sample of N = 720
participants. The sample was predominantly female
(491, 69.6%), university educated (387, 53.7%), employed
(591, 83.8%), married (288, 41%), and with a mean age of
38.9 years. The three groups did not differ on the demo-
graphic and clinical history variables assessed at baseline,
with two exceptions: WL participants (66%) were more
likely than myCompass (58%) and AC (52%) participants
to report a stressful episode in the month preceding the
study (X2 = 8.08, P < 0.02), and had a significantly lower
score at baseline on the DASS Anxiety subscale than
myCompass participants (F2, 702 = 4.44, P = 0.01; Table 1).
The rate of attrition for the total sample was 27.9% at
post-intervention and 51.4% at the 3-month follow-up
assessment (see Figure 1). At post-intervention, attrition
was higher among employed (27.9%) than unemployed
participants (18.4%; X21 = 4.04, P = 0.04), slightly higher
in males (31.6%) than females (24.4%; X21 = 3.77, P = 0
.05) and higher in the myCompass group (45.5%) than
the AC (20.7%) and WL groups (13.2%; X22 = 67.84, P <
0.001). Those who did not complete the post-intervention
assessment also reported significantly lower DASS Anxiety
scores at baseline (t703 = −1.96, P = 0.05). Attrition rates at
3-month follow-up were 56.7% and 32.1%, for the
myCompass and AC groups respectively, and differed sig-
nificantly (X21 = 29.25, P < 0.001). Demographic variables
did not differ between dropouts and non-dropouts at follow-
up, however, dropouts reported significantly less functional
impairment at baseline on the WSAS (t703 =−2.01, P= 0.04).
For the myCompass group, there were no significant
baseline differences between non-dropouts and dropouts
at post-intervention and follow-up on any of the demo-
graphic and clinical history variables.
Outcomes at post-intervention
Table 2 reports observed and estimated marginal mean
(EMM) scores on the study outcomes at baseline, post-
intervention and follow-up for the three groups.
The MMRM analyses of pre-post intervention data
yielded significant 3 (groups) by 2 (times) interactions
across the DASS subscales and total scores and the
WSAS (Table 3). Bonferroni adjusted contrasts compar-
ing change from baseline for each group showed a con-
sistent pattern of significantly greater improvement at
Table 1 Demographic and clinical characteristics of the
intervention, attention control (AC) and waitlist (WL)
groups at baseline
Characteristics myCompass Attention
control
Wait list
(n = 231) (n = 246) (n = 228)
Socio-demographics
Mean age (SD) 39 (10.73) 40 (11.42) 38 (10.26)
Female 160 (70%) 170 (70%) 161(70%)
Married 97 (42%) 104 (42%) 87 (38%)
Employed 196 (85%) 206 (84%) 189 (83%)
Student 46 (20%) 53 (22%) 47 (21%)
Education level
Secondary school or lower 25 (11%) 47 (19%) 41 (18%)
Trade certificate or diploma 70 (30%) 79 (32%) 50 (22%)
University under-graduate or
more
135 (58%) 118 (48%) 134 (59%)
Daily computer use 225 (97%) 234 (95%) 219 (96%)
Daily mobile phone use 223 (96%) 234 (95%) 220 (96%)
Clinical history
Experienced an episode
Depression 201 (87%) 222 (90%) 198 (87%)
Anxiety 188 (81%) 208 (85%) 196 (86%)
Stress 221 (96%) 241 (98%) 225 (99%)
Frequency of previous episodes
Depression - > 5 times 116 (50%) 109 (44%) 106 (46%)
Anxiety - > 5 times 106 (46%) 107 (43%) 108 (47%)
Stress - > 5 times 153 (66%) 146 (59%) 132 (58%)
Episode in the last month
Depression 82 (35%) 108 (44%) 89 (39%)
Anxiety 68 (29%) 87 (35%) 87 (38%)
Stress 134 (58%) 129 (52%) 151 (66%)
Distress caused by most recent episode (Mean, SD)a
Depression 7.98 (1.78) 7.75 (2.25) 8.09 (2.06)
Anxiety 7.82 (1.67) 7.44 (1.92) 8.02 (1.89)
Stress 7.64 (1.75) 7.54 (2.07) 7.52 (2.08)
Comorbid symptomsb 140 (61%) 161 (65%) 149 (65%)
aScores ranged 0 (No distress) to 10 (Extremely distressing).
bScores in the mild range or higher on two or more of the DASS subscales.
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post-intervention for the myCompass group compared
to the AC and WL groups on the Depression, Anxiety,
DASS Total and WSAS scales. Compared to the WL
group, myCompass participants also showed significant
gains on the Stress scale.
Outcomes at follow-up
Figures 2 and 3 depict the estimated marginal means for
the myCompass and AC conditions on the primary and
secondary outcome measures at baseline, post-intervention
and follow-up.
When data for the myCompass and AC groups at the
three time points were subjected to MMRM analysis, sig-
nificant overall group by time interactions were observed
across all of the primary and secondary measures, except
for the DASS Stress subscale (F2, 800 = 5.33, P = 0.12). In
these analyses, the interaction contrasts computed for the
intervention phase examined the same group differences
as the contrast comparing the myCompass and AC group
reported in Table 3. Interaction contrasts comparing
groups during the follow-up phase showed significantly
greater change for the AC group than the myCompass
group on the WSAS, DASS Depression and DASS Total
scales. Within-group comparisons of means in the
myCompass group showed that treatment gains were
maintained from post-test through the follow-up phase,
with scores remaining low and stable, the only exception
being a small increase in DASS Depression scores (mean
difference = 1.52, P = 0.05) Table 4.
Effect size
Between- and within-group effect sizes on the primary
and secondary outcomes calculated using observed and
adjusted means are presented in Table 5. At post-
intervention, between-group effect sizes calculated using
observed means ranged from small-to-moderate (myCom-
pass vs. AC; d range = .22 - .41: myCompass vs. WL; d
range = .29 to .55), with effect sizes based on adjusted
Table 2 Observed and estimated marginal means (EMM), including SD and SEM, at pre-and post-intervention and
follow-up for each group
myCompass Attention control Wait lista
n’s at each time-point
Baseline 231 246 228
Post-intervention 126 195 198
Follow-up 100 167 -
Outcome Mean (SD) EMM (SEM) Mean (SD) EMM (SEM) Mean (SD) EMM (SEM)
WSAS
Baseline 16.78 (8.07) 16.79 (0.29) 16.69 (8.11) 16.73 (0.28) 16.56 (8.77) 16.79 (0.29)
Post-intervention 12.63 (8.30) 12.26 (0.41) 14.42 (9.47) 14.41 (0.32) 15.03 (8.97) 15.05 (0.32)
Follow-up 12.02 (8.83) 12.13 (0.54) 13.26 (9.05) 13.27 (0.42) -
DASS depression
Baseline 15.09 (9.44) 14.98 (0.34) 15.10 (8.88) 14.98 (0.33) 14.83 (8.90) 14.98 (0.34)
Post-intervention 10.62 (8.41) 10.57 (0.47) 13.84 (10.41) 13.82 (0.37) 14.82 (9.96) 14.95 (0.37)
Follow-up 11.68 (9.86) 12.14 (0.61) 12.59 (9.53) 12.51 (0.47) -
DASS anxiety
Baselineb 7.31 (6.47) 8.55 (0.27) 8.83 (7.05) 8.55 (0.26) 9.09 (7.27) 8.55 (0.27)
Post-intervention 5.63 (6.74) 6.40 (0.37) 8.43 (8.18) 8.17 (0.29) 8.91 (7.98) 8.38 (0.29)
Follow-up 6.78 (7.31) 7.00 (0.46) 7.43 (7.41) 7.15 (0.36) -
DASS stress
Baseline 18.12 (8.02) 18.45 (0.32) 18.46 (8.72) 18.45 (0.31) 18.67 (7.91) 18.45 (0.32)
Post-intervention 14.94 (7.62) 15.17 (0.43) 16.73 (8.95) 16.76 (0.34) 17.82 (8.96) 17.47 (0.34)
Follow-up 14.26 (8.37) 14.66 (0.56) 16.00 (9.18) 15.84 (0.44) -
DASS total score
Baseline 40.53 (18.94) 41.99 (0.79) 42.40 (19.53) 41.99 (0.76) 42.60 (18.45) 41.99 (0.79)
Post-intervention 31.20 (19.31) 31.88 (1.08) 39.01 (23.94) 38.76 (0.87) 41.56 (22.11) 40.72 (0.86)
Follow-up 32.74 (22.13) 33.90 (1.42) 36.03 (22.69) 35.48 (1.10) -
aWL participants were given access to myCompass after the post-intervention assessment so no follow-up data are reported.
bWL significantly greater than intervention, P = .01.
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means tending to be only marginally lower. Within-group
effects for the myCompass group were mostly moderate
based on observed means (d range = .24 to .49), and
slightly larger based on adjusted means. For the AC
and WL groups, within-group effects were generally small
(d range = .01 to .27).
Waitlist group results
WL participants were given access to myCompass at the
end of the waiting period, and 52% (103) returned a ques-
tionnaire after using the myCompass intervention for
seven weeks. Paired samples t-tests showed significant im-
mediate improvement for participants on the three
DASS subscales and the total DASS (t101 range = 1.97-
3.10; P range 0.001 to 0.05) and on the WSAS (t95 =
2.94; P = .004). Follow-up data were provided by 66%
(68) of this group and showed that these improvements
were maintained at follow-up (t67 range = −1.22-1.30; NS).
Within-group effect sizes calculated immediately after
the intervention and using observed means were
small (d range = .17 for DASS Anxiety to .31 for DASS
Depression).
Program adherence and satisfaction
Participants in the intervention group logged in to use the
myCompass program an average of 14.7 times (s.d.=16.7;
Table 3 Outcomes of mixed models analyses at baseline and post-intervention for all groups
Effect Contrast estimate df (numerator, denominator) F, t statistica P Confidence intervalsb
WSAS
Group x time: 2, 764 9.225 .000
Interaction contrasts:
myCompass vs. ACc 2.12 1, 802 3.23 .001 0.55-3.70
myCompass vs. WL 2.77 1, 792 4.18 .000 1.18-4.36
AC vs. WL 0.65 1, 711 0.28 .286 −0.81-2.10
DASS depression
Group x time 2, 757 17.16 .000
Interaction contrasts:
myCompass vs. AC 3.25 1, 794 4.27 .000 1.42-5.08
myCompass vs. WL 4.39 1, 779 5.72 .000 2.55-6.23
AC vs. WL 1.13 1, 709 1.59 .111 −0.57-2.83
DASS anxiety
Group x time 2, 760 6.11 .002
Interaction contrasts:
myCompass vs. AC 1.76 1, 796 2.93 .004 0.32-3.21
myCompass vs. WL 1.96 1, 782 3.25 .001 0.51-3.42
AC vs. WL 0.20 1, 711 0.36 .714 −1.13-1.54
DASS stress
Group x time 2, 758 5.33 .005
Interaction contrasts:
myCompass vs. AC 1.59 1, 795 2.25 .025 −0.11-3.29
myCompass vs. WL 2.29 1, 780 3.22 .001 0.50-4.00
AC vs. WL 0.71 1, 710 1.07 .283 −0.87-2.28
DASS total score
Group x time 2, 758 13.065 .000
Interaction contrasts:
myCompass vs. AC 6.83 1, 794 3.86 .000 2.59-11.97
myCompass vs. WL 8.79 1, 780 4.95 .000 4.53-13.05
AC vs. WL 1.95 1, 709 1.19 .233 −1.93-5.90
aAs appropriate.
bBonferroni adjusted confidence intervals, P = .016.
c= ‘Attention Control’, WL = ‘Waitlist’.
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range 0 to 105) and self-monitored an average of 49 times
(s.d.=54.1; range 0 to 262) during the 7-week intervention
period. The mean number of modules completed was 1.6
(s.d.=1.7; range 0 to 9). There was no difference at baseline
between people who did and did not log in to use myCom-
pass during the intervention period. None of the adherence
indices correlated with demographic, clinical history and
primary and secondary outcome data obtained at baseline.
Scores on the program satisfaction measure ranged
from 1 (dissatisfied) to 5 (extremely satisfied). On aver-
age, ratings of program satisfaction were above the mid-
points of the scale and did not differ for participants in
the myCompass (mean rating = 3.86, s.d.=0.82) and AC
(mean rating = 3.66, s.d.=0.85) conditions (t299 = 1.92;
NS). Eighty-three per cent of myCompass participants
reported that they would recommend the program to
others, and 87.4% indicated that they would happily use
the program again.
Discussion
The myCompass intervention brought about rapid im-
provements in mental health symptoms and in work and
social functioning in a large community sample. At post-
intervention, the myCompass group showed significantly
reduced symptoms of depression, anxiety and stress, and
significantly improved levels of work and social func-
tioning. Mostly moderate within-group and small-to-
moderate between-group effects on the primary and
secondary outcome measures were found for myCom-
pass participants. Scores reduced to the normal range
by post-intervention and treatment gains were main-
tained at 3-month follow-up. Participants in the AC
condition showed gradual improvement over the post-
intervention period and no differences were observed
between myCompass and AC participants at 3 month
follow-up. The immediate within-group improvements
seen in the myCompass group were later replicated in
the WL group when they went through the myCom-
pass intervention at the conclusion of their 7-week
wait period.
These results demonstrate that delivery of CBT using
a combination of mobile phone and computer technol-
ogy is effective, acceptable to users and, consistent with
trials of web-based interventions delivered via stationary
devices, produces persistent benefits [29]. For depres-
sion, in particular, the current findings compare very
favourably to effect sizes achieved in other studies of au-
tomated, unassisted web-based interventions [30].
Figure 2 Estimated marginal DASS means for the intervention and attention control groups.
Figure 3 Estimated marginal WSAS means for the intervention
and attention control groups.
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During the follow-up phase, scores on the primary and
secondary outcomes for the myCompass group remained
improved, but at the 3-month follow-up no longer differed
from the AC group. This is likely to reflect the continued
improvement of the AC group, the complete withdrawal
of the active program in the myCompass group at seven
weeks, and the fact that most participants in the myCom-
pass group achieved ‘normal’ or ‘near-normal’ levels of
work and social functioning and mental health symptoms
after seven weeks (i.e., scoring at ‘floor’), leaving no room
for further improvement. The pattern of symptom im-
provement observed for the AC group is similar to the
natural course of symptom remission over several months
observed in untreated depression and anxiety [31,32].
In contrast, the myCompass intervention accelerated
symptom remission to within two months, producing
rapid benefit for those-in-need, and with effect sizes
predominantly in the moderate range. Work and social
functioning also significantly improved within two months
in the myCompass group, indicating that the program
positively impacts on the personal burden associated with
anxiety and mood disorders. These results were achieved
despite the smaller than planned final sample size, and
suggest a larger therapeutic benefit for myCompass than
was anticipated in the initial study design.
Limitations
Limitations of this research need to be acknowledged. In
common with previous internet trials [23,33], dropout
attrition was high, especially for the myCompass group,
and rates of engagement for myCompass participants
with the program content were highly variable (and in
some instances minimal). Inspection of possible biases
due to attrition showed that dropouts were more likely
to be male and employed, thus reducing our confidence
in generalising to these groups. While our statistical methods
accounted for dropout attrition and non-completion, we
cannot discount the possibility that dropouts from the inter-
vention group were less satisfied with the program and/or
experienced less positive outcomes. Further research is
Table 4 Outcomes of mixed models analyses at baseline,
post-intervention and follow-up for the myCompass and
attention control groups
Effect Contrast
estimate
df (numerator,
denominator)
F, t
statistica
p Confidence
intervalsb
WSAS
Group x time 2, 790 3.93 .020
Interaction contrasts:
Intervention
phasec
2.06 1, 790 2.77 .006 0.39-3.73
Follow-up phase −0.93 1, 761 −1.07 .281 −2.81-1.01
Depression
Group x time 2, 803 7.94 .000
Interaction contrasts:
Intervention
phase
3.22 1, 799 3.83 .000 1.33-5.10
Follow-up phase −2.85 1, 774 −2.91 .004 −5.05-−0.65
DASS anxiety
Group x time 2, 805 4.20 .015
Interaction contrasts:
Intervention
phase
1.76 1, 802 2.76 .006 0.33-3.21
Follow-up phase −1.62 1, 775 −2.18 .029 −3.29-−0.05
DASS stress
Group x time 2, 800 5.33 .120
Interaction contrasts:
Intervention
phase
1.48 1, 797 1.91 .056 −0.26-3.22
Follow-up phase −0.30 1, 770 −0.33 .721 −2.33-1.72
DASS total score
Group x time 2, 801 6.15 .002
Interaction contrasts:
Intervention
phase
6.73 1, 798 3.46 .001 2.91-10.55
Follow-up phase −5.14 1, 771 −2.27 .024 −9.59-−0.69
aAs appropriate.
bBonferroni adjusted confidence intervals, P= .025.
cAlthough the model is different, the intervention phase contrasts answer the same
question as those comparing the myCompass and Attention Control groups reported
in Table 3.
Table 5 Between and within-group effects at post-test
calculated using observed and estimated marginal means
(Cohen’s d)
WSAS DASS Subscales
Depression Anxiety Stress Total
Observed means
Between-groups:
myCompass vs. ACa .22 .36 .40 .22 .41
myCompass vs. WL .29 .46 .47 .35 .55
Within-groups:
myCompass .49 .49 .24 .39 .49
AC .27 .13 .06 .21 .18
WL .18 .00 .03 .10 .05
Estimated marginal means
Between-groups:
myCompass vs. AC .23 .33 .26 .19 .36
myCompass vs. WL .29 .48 .29 .28 .47
Within-groups:
myCompass .55 .49 .31 .40 .53
AC .28 .13 .05 .21 .17
WL .21 .00 .03 .11 .07
aAC = ‘Attention Control’, WL = ‘Waitlist’.
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required to examine the predictors of usage of the myCom-
pass program, and relations between program usage and
symptom and functional gains.
To the best of our knowledge, this is the first study to
demonstrate the effectiveness of mobile phone and com-
puter technology to deliver a fully automated, self-help inter-
vention for a community sample with depression, anxiety
and stress. Future research is needed to isolate the relative
contributions of the mobile phone (e.g., self-monitoring,
SMS messages) and computer-based (e.g., psycho-
educational modules) elements of the intervention.
We are currently planning a dismantling study com-
paring different program elements (e.g., mobile ver-
sus email self-monitoring; modules only versus modules
and self-monitoring), in order to identify the ‘active’ pro-
gram elements. Further research to quantify work prod-
uctivity improvements and monetary savings, and to
investigate the short-and long-term effectiveness of
myCompass in more severely distressed individuals is
also warranted.
Conclusion
Mobile phones are a highly accessible and practical
means of delivering CBT and facilitating self-monitoring
for people with mild-to-moderate mental health symp-
toms. Given the high prevalence of functional impairment
associated with mild-to-moderate anxiety and mood dis-
orders, resource-intensive interventions are not feasible
for addressing the substantial personal and economic
costs associated with unmet treatment need. Mobile
phone-enabled and internet-delivered interventions are
accessible, popular, and capable of being disseminated at
scale. myCompass is a fully automated public health inter-
vention without therapist support that people can use via
the internet on their mobile phones and computers. When
used for seven weeks, the program was effective in redu-
cing symptoms of mild-to-moderate depression, anxiety
and stress, and improving work and social functioning,
with improvements persisting for three months. These re-
sults are encouraging, and when the practical benefits of
accessibility, anonymity and ease of widespread dissemin-
ation are considered, they suggest that the combination of
mobile phone and internet technology provides an ideal
platform for the delivery of mental health care. A public
health intervention that is easily accessible, free to use,
and capable of producing reasonable symptom gains, in
the absence of therapist assistance, has the potential to be
of major benefit in population terms.
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